Made in USA

Independently verifiedCertified

GLOW Blend · 50/10/10 mg

Purity (HPLC)≥98% per component

LabVantage Analytical

Tested28 Jun 2026

Batch —·

Heavy metalsEndotoxinsMicrobialSolvents

View full COA

In stock

GLOW Blend

Name: GLOW Blend
Brand: AXOS
Availability: InStock

$139

Tri-peptide blend — GHK-Cu, BPC-157, TB-500 — gene expression and tissue repair research

Buy 1, Get 1 Free · auto-applied

Add 2+ items to cart to activate the discount

VISAAMEXPayPal

Secure, encrypted checkout

Independently verifiedCertified

GLOW Blend · 50/10/10 mg

Purity (HPLC)≥98% per component

LabVantage Analytical

Tested28 Jun 2026

Batch —·

Heavy metalsEndotoxinsMicrobialSolvents

View full COA

Frequently bought together

Researchers usually add these to complete the protocol.

BAC Water · 3ml

Essential · Extras

GHK-CU · 50mg

Recovery

$39

Melanotan 2 · 10mg

Tanning

$49

Add all (3)$97

Certificate of analysis

Every vial ships with its own report

We don't publish a brand-wide spec sheet and call it a “COA.” The certificate you receive references the actual lot number stamped on your vial — with the raw chromatograms attached.

Lot-specific HPLC purity + LC-MS identity
Raw chromatogram + mass confirmation attached
Signed off by the lab's Principal Chemist
Permanent archive — searchable by lot ID

View all lab reports

Reference reportView All Live Reports

Vantage Analytical

Independent analytical lab

Certificate of Analysis

RESULT · PASS

ProductGLOW Blend · 50/10/10 mg

Lot / batch—

Reported28 Jun 2026

MethodHPLC-UV + LC-MS

AppearanceWhite lyophilized powder

ClientSolace Peptides

Analytical results

Identity (LC-MS)1419.5 DaPASS

Purity (HPLC-UV)≥98% per componentPASS

Net content10.2 mgPASS

Endotoxin (LAL)< 0.05 EU/mgPASS

Heavy metals (ICP-MS)< 10 ppmPASS

Residual solventsBelow LOQPASS

HPLC Chromatogram

Purity ≥98% per component

Chemist verifiedDr. E. Hartley

Know your compound

What is GLOW Blend?

GLOW Blend is a three-peptide research formulation comprising GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) — compounds belonging to copper-binding tripeptides, pentadecapeptides, and thymosin-beta-4 fragments, respectively. Each component has an established preclinical literature addressing distinct molecular targets in gene regulation, angiogenesis, and cytoskeletal dynamics.

GHK-Cu is studied because, in a transcriptomic analysis, it was associated with differential modulation of 4,192 human genes, with expression shifts toward patterns observed in younger tissue — a scale of gene-regulatory activity that distinguishes it from most single-peptide research tools. BPC-157 and TB-500 are paired as complementary probes of vascular and migratory repair mechanisms respectively, across hundreds of published animal-model studies.

GHK-Cu associated with modulation of 4,192 human genes toward younger expression profiles (Pickart & Margolina, transcriptomic study)
BPC-157 associated with 50–72% acceleration in tissue healing endpoints in rodent models (Sikiric et al.)
TB-500 linked to stem cell mobilisation and reduced fibrosis in preclinical repair models

Lot-specific COAEvery lot ships with an HPLC Certificate of Analysis and mass-spectrometry identity confirmation.

Institutional fulfilmentShipped to verified institutional addresses with full analytical documentation.

Lot-specific COA: Every lot ships with an HPLC Certificate of Analysis and mass-spectrometry identity confirmation.
Institutional fulfilment: Shipped to verified institutional addresses with full analytical documentation.

For research use only — not for human or veterinary use.

The research

What the research actually found

The published findings behind this compound — the headline numbers, in plain terms, each cited to source. Preclinical results are directional (animal / in-vitro) and shown for context, not as therapeutic claims.

Published research on the reference compound class. Provided for scientific context only — not a claim about the product supplied.

Gene activityPreclinical

4,192

In a human transcriptomic analysis, GHK-Cu was associated with differential modulation of 4,192 genes — shifting expression patterns toward profiles observed in younger tissue, a breadth of gene-regulatory signal rarely reported for a single peptide.

in vitro · human transcriptomic model

Biochemistry Insights · Pickart & Margolina 2018

4,192 genes

Human genes modulated toward younger expression profiles

Transcriptomic analysis, human gene expression model — Pickart & Margolina 2018. Not a clinical outcome.

Tissue healingPreclinical

50–72%

In rodent surgical and wound models, BPC-157 treatment was associated with 50–72% faster healing across multiple tissue endpoints compared with untreated controls, according to Sikiric et al.

vs. untreated controls · rodent models

BPC-157+50–72% vs. control

Untreated controlbaseline

Bars represent relative healing endpoint scores in rodent surgical/wound models — Sikiric et al. Magnitude anchored to BPC-157 arm. Not a clinical outcome.

Journal of Physiology — Paris · Sikiric et al.

Fibrosis & repairPreclinical

In animal tissue repair models, TB-500 (Thymosin β4) was associated with reduced fibrotic deposition and documented stem cell mobilisation relative to controls — two complementary signals in preclinical repair research, per Annals of the New York Academy of Sciences.

Injury

Tissue damage induced in animal model

TB-500 treatment

Thymosin β4 administered post-injury

Stem cell mobilisation

Preclinical repair model observation

Reduced fibrosis

Lower fibrotic deposition vs. controls

Directional findings from animal repair models — no precise percentage available in supplied sources. Not a clinical outcome.

Annals of the New York Academy of Sciences · 2013

GLOW Blend (50/10/10 mg) — molecular specimen

Gene RegulationGHK-Cu / transcriptomic

AngiogenesisBPC-157 / VEGFR2 pathway

Cell MigrationTB-500 / actin dynamics

Mechanism

How GLOW Blend works

The three components of GLOW Blend are studied to act through distinct molecular routes: transcriptional reprogramming, pro-angiogenic receptor signalling, and cytoskeletal remodelling.

Gene RegulationGHK-Cu / transcriptomic

GHK-Cu is studied as a modulator of broad gene-expression programmes — in transcriptomic models it is associated with shifts in the activity of thousands of genes linked to extracellular matrix maintenance and oxidative-stress response.

AngiogenesisBPC-157 / VEGFR2 pathway

BPC-157 is investigated for its capacity to upregulate VEGFR2-mediated signalling, promoting endothelial sprouting and new vessel formation in rodent wound and surgical models.

Cell MigrationTB-500 / actin dynamics

TB-500 (Tβ4 fragment) is studied for its role in sequestering G-actin, facilitating lamellipodia formation and directed cell migration — a mechanism implicated in tissue remodelling and fibrosis reduction in preclinical assays.

For research use only. Mechanisms described reflect published preclinical and clinical literature.

The process

How every batch is verified

01
Synthesized
Produced under controlled manufacturing with documented, repeatable processes.
02
HPLC purity
An independent lab reports the exact purity of every lot — a number, never a 'passes'.
03
Mass-spec identity
Molecular weight confirms the exact sequence is what the label says.
04
COA published
The certificate is posted to the open library, by lot, before the vial ships.

Verified researchers

Reviewed by people who test it themselves

Best sellers

Researchers reach for these

Best seller

5 Amino 1MQ

50mg

5.0

≥98% HPLC

$89

Best seller

BAC Water

10ml

5.0

$19

BPC-157

10mg

5.0

≥98% HPLC

$69

BPC-157 + TB-500

10mg + 10mg

5.0

≥98% HPLC

$119

CJC / Ipamorelin

5mg + 5mg

5.0

>98% HPLC

$99

CJC-1295 with DAC

5mg

5.0

≥98% HPLC

$79

FAQ

Frequently asked

Common questions about GLOW Blend

The COA guarantee

≥98% per component pure — or your money back.

Have any lot independently re-tested. If the results don't match the published certificate, we refund the order in full — no returns, no questions.

Order with cover

Third-party tested

An independent, accredited lab — no commercial interest in the result.

A COA on every lot

A lot-specific certificate ships with each vial, archived by batch.

Test it yourself → refund

Re-test any batch at any lab. A mismatch is a full refund.

Every vial ships with its own report

We don't publish a brand-wide spec sheet and call it a “COA.” The certificate you receive references the actual lot number stamped on your vial — with the raw chromatograms attached.

Lot-specific HPLC purity + LC-MS identity

Raw chromatogram + mass confirmation attached

Signed off by the lab's Principal Chemist

Permanent archive — searchable by lot ID

View all lab reports

What is GLOW Blend?

GHK-Cu associated with modulation of 4,192 human genes toward younger expression profiles (Pickart & Margolina, transcriptomic study)

BPC-157 associated with 50–72% acceleration in tissue healing endpoints in rodent models (Sikiric et al.)

TB-500 linked to stem cell mobilisation and reduced fibrosis in preclinical repair models

How GLOW Blend works

The three components of GLOW Blend are studied to act through distinct molecular routes: transcriptional reprogramming, pro-angiogenic receptor signalling, and cytoskeletal remodelling.